Increased long-term bleeding complications in females undergoing endovascular revascularization for peripheral arterial disease

Keyphrases

• Peripheral Arterial Disease 100%
• Bleeding Events 100%
• Bleeding Complications 100%
• Endovascular Revascularization 100%
• Antiplatelet Therapy 60%
• Endovascular Intervention 60%
• Anticoagulant Therapy 60%
• Antithrombotic Therapy 60%
• High Incidence 40%
• Airway 40%
• Bleeding Risk 40%
• Cumulative Incidence 40%
• Sex Differences 20%
• Low Incidence 20%
• Bleeding 20%
• Procedural Complications 20%
• Anticoagulation 20%
• Anticoagulants 20%
• Coagulopathy 20%
• Competing Risks 20%
• Post-procedural 20%
• One Percent 20%
• Hematoma 20%
• Gender Disparity 20%
• Clopidogrel 20%
• Gastrointestinal 20%
• Gastrointestinal Bleeding 20%
• Endovascular Therapy 20%
• Risk Difference 20%
• No Prescription 20%
• Medicare Claims Data 20%
• Antiplatelet 20%
• Intracranial Hematoma 20%
• Aalen-Johansen Estimator 20%
• Dual Antiplatelet Therapy 20%

Medicine and Dentistry

• Bleeding 100%
• Arteriosclerosis Obliterans 100%
• Revascularization 100%
• Antiplatelet 71%
• Anticoagulant Therapy 42%
• Antithrombotic Therapy 42%
• Cumulative Incidence 28%
• Limb 14%
• Coagulopathy 14%
• Sex Difference 14%
• Anticoagulation 14%
• Medicare 14%
• Anticoagulant 14%
• Hematoma 14%
• Endovascular Surgery 14%
• Gastrointestinal Bleeding 14%
• Brain Hematoma 14%
• Attributable Risk 14%
• Clopidogrel 14%